by Case Western Reserve University Credit: SHVETS production from Pexels Researchers at the Case Western Reserve School of Medicine have found that when compared to seven other anti-diabetic drugs, semaglutide, a popular diabetes and weight-loss drug, may lower the risk of Alzheimer’s disease in people with type 2 diabetes (T2D). Alzheimer’s disease is a brain disorder...
Tag: <span>Alzheimers</span>
Post
Study finds common sleeping pill may reduce Alzheimer’s protein buildup, ScienceAlert reports
Study finds common sleeping pill may reduce Alzheimer’s protein buildup, ScienceAlert reports – © The Daily Galaxy –Great Discoveries Channel The relationship between sleep quality and Alzheimer’s disease has long intrigued researchers. Poor sleep patterns have been identified as an early warning sign of Alzheimer’s, often preceding more noticeable symptoms like memory loss and cognitive decline. Scientists...
Post
Could a once-daily pill for seizures also treat Alzheimer’s disease?
A once-a-day pill used to treat seizures could also help treat Alzheimer’s disease, a new study suggests. Image credit: Viktoriya Skorikova/Getty Images. Past research shows that for many people, mild cognitive impairmentTrusted Source can be the first sign of Alzheimer’s disease. About one-third of people who have mild cognitive impairment because of Alzheimer’s disease progresses to dementia within 5 years. “Our studies...
Post
New Diagnostic Criteria for Alzheimer’s Will Change Practice
Neil Skolnik, MD DISCLOSURES | September 10, 2024 This transcript has been edited for clarity. I’m Dr Neil Skolnik and today I’m going to talk about the Revised criteria for diagnosis and staging of Alzheimer’s disease (AD) from the Alzheimer’s Association Workgroup. This is a big deal that will fundamentally change the way we will...
Post
Alzheimer’s-like brain changes found in long COVID patients
September 2, 2024 by Hillary Smith, University of Kentucky UK researchers find Alzheimer’s-like brain changes in long COVID patientsResearch illustration by Tom Dolan. Credit: University of KentuckyNew research from the University of Kentucky’s Sanders-Brown Center on Aging shows compelling evidence that the cognitive impairments observed in long COVID patients share striking similarities with those seen...
Post
Q&A: Expert explains the reliability of Alzheimer’s blood tests
August 20, 2024 by Marla Paul, Northwestern University Credit: CC0 Public Domain Just as your primary care physician offers routine blood tests to gauge cholesterol or glucose levels, they might soon offer a blood test to diagnose Alzheimer’s disease. Two papers presented recently at the Alzheimer’s Association International Conference (AAIC 2024) add to growing evidence...
Post
Possible explanation for link between diabetes and Alzheimer’s
News Release 12-Aug-2024 Peer-Reviewed PublicationUmea University image: Professor Olov Rolandsson, Department of Public Health and Clinical Medicine, Umeå University Credit: Mattias Pettersson People with type 2 diabetes are at increased risk of Alzheimer’s disease and other cognitive problems. A new study led by Umeå University, Sweden, shows that the reason may be that people with...
Post
Potential new target for early treatment of Alzheimer’s disease – Alzheimer’s
Disrupting a class of sugar-modified proteins improves cell repair, rescues neuron loss and reverses cellular changes associated with neurodegenerative diseases, researchers report. IMAGE: MUTATIONS IN THE PRESENILIN GENE, PSEN1, CAUSES EARLY ONSET OF ALZHEIMER’S DISEASE IN HUMANS AND IN FRUIT FLIES MODIFIED TO HAVE THIS GENE. A NEW STUDY LED BY RESEARCHERS AT PENN STATE...
Post
How we can slow down or prevent Alzheimer’s
JUNE 25, 2024 by Murdoch University Plots for the relationship between baseline sleep duration category and the trajectory of brain Aβ burden, in cognitively unimpaired APOE ε4 allele non-carriers (left) and carriers (right). Plots for the relationship between baseline sleep duration category and the trajectory of brain Aβ burden, in cognitively unimpaired APOE ε4 allele...
Post
Alzheimer’s biomarker sTREM2 plays a causal, potentially modifiable, role in disease
MAY 31, 2024 by Washington University in St. Louis Credit: Pixabay/CC0 Public Domain The protein sTREM2 plays a crucial role in Alzheimer’s disease, but the role is complex and poorly understood. In the early stages of the disease, sTREM2 levels in the cerebrospinal fluid fall relative to healthy people’s, but then the levels rise far...